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Following the publication of the article 'The enhanced
expression of the matrix metalloproteinase 9 in nasal NK/
T-cell lymphoma. BMC Cancer 2007, 7:229' [1], the sub-
mitting author became aware that a co-author had been
omitted from the publication. Therefore, this article has
been submitted as a correction to the original text, and
highlights the contributions that this author made to the
original article. The author would like to apologize for any
inconvenience this may have caused.
Corrected author list
Koh-ichi Sakata, Masanori Someya, Mutsuko Omatsu,
Hiroko Asanuma, Tadashi Hasegawa, Shingo Ichimiya,
Masato Hareyama, and Tetsuo Himi.
Corrected authors' contributions
KS and MS carried out immunohistochemical examina-
tions and drafted the manuscript. MH and TH (Tetsuo
HiMi) treated patients and statistical analyses. MO, HA,
and TH (Takashi Hasegawa) performed the histological
diagnosis and in situ hybridization. SI improved the
method to detect EBER in the nucleus of nasal T cell lym-
phoma cells by RNA-DNA in situ hybridization and
attended pathological diagnosis of nasal T cell lym-
phoma. All authors read and approved the final abstract.
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